Literature DB >> 28596643

Platelets: Pathophysiological Relevance and Therapeutic Potential.

Hara Prasad Pati1, Prashant Sharma2.   

Abstract

Year:  2017        PMID： 28596643      PMCID： PMC5442071          DOI： 10.1007/s12288-017-0823-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  10 in total

1.  Platelet apoptosis resistance and increased CXCR4 expression in pediatric patients with chronic immune thrombocytopenic purpura.

Authors:  Jiaan-Der Wang; Ting-Tsz Ou; Chau-Jong Wang; Te-Kau Chang; Huei-Jane Lee
Journal:  Thromb Res       Date:  2010-08-13       Impact factor: 3.944

2.  Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1.

Authors:  Bob Olsson; Börje Ridell; Lena Carlsson; Stefan Jacobsson; Hans Wadenvik
Journal:  Blood       Date:  2008-06-02       Impact factor: 22.113

3.  Mean platelet volume may not be an alternative test instead of platelet aggregation in patients with venous thromboembolism.

Authors:  Cengiz Beyan; Esin Beyan
Journal:  Thromb Res       Date:  2017-03-14       Impact factor: 3.944

Review 4.  Platelet Derived Biomaterials for Therapeutic Use: Review of Technical Aspects.

Authors:  Satyam Arora; Naveen Agnihotri
Journal:  Indian J Hematol Blood Transfus       Date:  2016-03-29       Impact factor: 0.900

5.  A Correlation of the Platelet Count with D-Dimer Levels as an Indicator for Component Therapy in Children with Dengue Hemorrhagic Fever.

Authors:  Arthi Sridhar; B M Sunil Kumar; Aarathi Rau; A T K Rau
Journal:  Indian J Hematol Blood Transfus       Date:  2016-05-24       Impact factor: 0.900

6.  The Impact of Mean Platelet Volume (MPV) and JAK-2 Mutation on Thrombosis in Chronic Myeloproliferative Diseases.

Authors:  Mesut Ayer; İlhan Menken; Mehmet Yamak; Fatma Aylin Ayer; Onur Kırkızlar; M Burak Aktuğlu
Journal:  Indian J Hematol Blood Transfus       Date:  2016-05-24       Impact factor: 0.900

7.  Is There a Relationship Between CXCR4 Gene Expression and Prognosis of Immune Thrombocytopenia in Children?

Authors:  Sajedeh Saeidi; Javad Mohammadi-Asl; Mohammad Ali Jalali Far; Ali Amin Asnafi; Firouzeh Dehuri; Yousef Tavakolifar; Najmaldin Saki
Journal:  Indian J Hematol Blood Transfus       Date:  2016-01-22       Impact factor: 0.900

8.  Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura.

Authors:  Kang-Hsi Wu; Ching-Tien Peng; Tsai-Chung Li; Lei Wan; Chang-Hai Tsai; Shou-Jen Lan; Ming-Cheng Chang; Fuu-Jen Tsai
Journal:  Br J Haematol       Date:  2005-03       Impact factor: 6.998

9.  Role of transforming growth factor-beta 1 gene polymorphisms in childhood idiopathic thrombocytopenic purpura.

Authors:  Berna Atabay; Hale Oren; Gülersu Irken; Sefa Kizildağ; Sunay Tunali; Meral Türker; Sebnem Yilmaz
Journal:  J Pediatr Hematol Oncol       Date:  2003-11       Impact factor: 1.289

Review 10.  Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis.

Authors:  Katja M J Heitink-Pollé; Joyce Nijsten; Chantal W B Boonacker; Masja de Haas; Marrie C A Bruin
Journal:  Blood       Date:  2014-10-10       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.